Dupilumab and Psoriasis Risk in Patients With Atopic Dermatitis: A Multicenter Cohort Study.

Block BR, Mehta J, Tang A, Ungar B, Gulati N

Open source

DOI
10.1111/exd.70378
Published
2026 Oct
Container
Experimental dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/exd.70378,
  title = {Dupilumab and Psoriasis Risk in Patients With Atopic Dermatitis: A Multicenter Cohort Study.},
  author = {Block BR and Mehta J and Tang A and Ungar B and Gulati N},
  year = {2026},
  journal = {Experimental dermatology},
  doi = {10.1111/exd.70378},
  url = {https://doi.org/10.1111/exd.70378}
}

RIS

TY  - JOUR
TI  - Dupilumab and Psoriasis Risk in Patients With Atopic Dermatitis: A Multicenter Cohort Study.
AU  - Block BR
AU  - Mehta J
AU  - Tang A
AU  - Ungar B
AU  - Gulati N
PY  - 2026
JO  - Experimental dermatology
DO  - 10.1111/exd.70378
UR  - https://doi.org/10.1111/exd.70378
ER  - 

APA

BR, B., J, M., A, T., B, U., & N, G. (2026). Dupilumab and Psoriasis Risk in Patients With Atopic Dermatitis: A Multicenter Cohort Study.. Experimental dermatology. https://doi.org/10.1111/exd.70378

Source records